Tamil Nadu, India

Chandru Sekaran

This inventor holds 1 USPTO granted patent. Top assignee: Honeywell International Inc.. Active years: 2014.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Chandru Sekaran

Introduction

Chandru Sekaran is an accomplished inventor based in Tamil Nadu, India. He has made significant contributions to the field of aviation technology. His innovative work focuses on enhancing the display systems used in aircraft.

Latest Patents

Chandru Sekaran holds a patent for "Systems and methods for displaying runway information." This patent describes a display system and method for an aircraft. The display device includes a processing unit that receives arrestor bed information associated with a runway. It generates display commands based on this information. The display device is coupled to the processing unit and is configured to receive the display commands. It displays symbology representing the arrestor bed information.

Career Highlights

Chandru Sekaran is currently employed at Honeywell International Inc., a leading company in aerospace and technology. His work at Honeywell has allowed him to apply his innovative ideas in practical applications. He has demonstrated a commitment to improving aviation safety and efficiency through his inventions.

Collaborations

Chandru has collaborated with talented coworkers, including Subash Samuthirapandian and Fazurudheen A. These collaborations have fostered a creative environment that encourages innovation and problem-solving.

Conclusion

Chandru Sekaran's contributions to aviation technology through his patent and work at Honeywell International Inc. highlight his role as a significant inventor in the field. His innovative spirit continues to drive advancements in aircraft display systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…